Global Flow Diversion Aneurysm Treatment Market Analysis & Forecasts 2018-2022, With an Expected CAGR of 14% - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Aug 7, 2018--The “Global Flow Diversion Aneurysm Treatment Market 2018-2022” report has been added to ResearchAndMarkets.com’s offering.
The analysts forecast the Global Flow Diversion Aneurysm Treatment Market to grow at a CAGR of 14% during the period 2018-2022.
Flow diversion aneurysm treatment consists of the use of endovascular devices such as flow-diverting stents (FDS) and intrasaccular flow disruption devices. These devices are used in the treatment of intracranial aneurysms (IAs).
The report covers the present scenario and the growth prospects of the flow diversion aneurysm treatment market. To calculate the market size, the report considers the revenue generated from the sales of products such as flow-diverting stents (FDS) and intrasaccular flow disruption devices.
The increasing R&D focus will be a key trend driving the market growth. Several manufacturers of neuroendovascular treatment devices are investing in R&D, owing to the increasing acceptance of flow diversion practices in clinical practices. Several companies are also conducting clinical trials to test the efficacy of their flow diversion devices.
The increasing prevalence of IAs and associated risk factors will drive the market growth. The prevalence of IAs is increasing globally and significant amount of individuals die every year due to ruptured brain aneurysms. With the increased average life expectancy increasing the aging population, the aged population globally segment are highly susceptible to acquiring IAs.
The report states that the lack of awareness and access to flow diversion procedures in emerging countries will impact the market growth. Developing countries witness a significant lack of awareness about flow diversion procedures among clinicians and the general population. Also, several regions are understaffed of skilled neurosurgeons and neurologists capable of performing flow diversion procedures.
Companies MentionedAcandis Medtronic Phenox Stryker TERUMO CORPORATION
Key Topics Covered:
01. Executive Summary
02. Scope Of The Report
03. Research Methodology
04. Market Landscape
05. Market Sizing
06. Five Forces Analysis
07. Market Segmentation By Product
08. Customer Landscape
09. Regional Landscape
10. Decision Framework
11. Drivers And Challenges
12. Market Trends
13. Vendor Landscape
14. Vendor Analysis
For more information about this report visit https://www.researchandmarkets.com/research/kjrj7h/global_flow?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180807005404/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Cardiovascular Drugs
INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 08/07/2018 06:54 AM/DISC: 08/07/2018 06:54 AM